Business

Correction: Holding(s) in Company

Correction: Holding(s) in Company.

articleNuformix PlcApril 8, 20215/company/nuformix-plc/news/correction-holdings-in-company-15
Correction: Holding(s) in Company

About this update from Nuformix Plc

[{"type":"text","content":"\n \n \n \n RNS Number : 8819U\n Nuformix PLC\n 08 April 2021\n  \n \n \n \n The following amendments have been made to the 'Holding(s) in Company' announcement released on 08/04/2021 at 11:54 a.m. under RNS No 8529U.\n \n \n  \n \n \n The resulting situation on the date on which threshold was crossed or reached is <3%.\n \n \n  \n \n \n The direct % of voting rights is \n <3%.\n \n \n  \n \n \n The SUBTOTAL 8. A is <3%.\n \n \n  \n \n \n All other details remain unchanged.\n \n \n  \n \n \n \n TR-1: S\n \n \n tandard form for notification of major holdings\n \n \n \n  \n \n \n \n \n \n \n NOTIFICATION OF MAJOR HOLDINGS\n \n \n \n \n (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)\n \n i\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached\n \n \n ii\n \n \n :\n \n \n \n \n \n \n Nuformix PLC\n \n \n \n \n \n \n \n 1b. Please indicate if the issuer is a non-UK issuer  \n \n (please mark with an \"X\" if appropriate)\n \n \n \n \n \n \n Non-UK issuer\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n 2. Reason for the notification \n \n (please mark the appropriate box or boxes with an \"X\")\n \n \n \n \n \n \n An acquisition or disposal of voting rights\n \n \n \n \n x\n \n \n \n \n \n \n An acquisition or disposal of financial instruments\n \n \n \n \n \n \n \n \n \n \n \n \n \n An event changing the breakdown of voting rights\n \n \n \n \n \n \n \n \n \n \n \n \n \n Other (please specify)iii:\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n 3. Details of person subject to the notification obligation\n \n \n iv\n \n \n \n \n \n \n \n Name\n \n \n \n \n David Tapolczay\n \n \n \n \n \n \n City and country of registered office (if applicable)\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n 4. Full name of shareholder(s)\n \n (if different from 3.)\n \n v\n \n \n \n \n \n \n \n Name\n \n \n \n \n \n \n \n \n \n \n \n \n \n City and country of registered office (if applicable)\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n 5. Date on which the threshold was crossed or reached\n \n \n vi\n \n \n :\n \n \n \n \n \n 30/03/2021\n \n \n \n \n \n \n 6. Date on which issuer notified (DD/MM/YYYY):\n \n \n \n \n 07/04/2021\n \n \n \n \n \n \n 7. Total positions of p...

More updates from Nuformix Plc